PAR, a novel androgen regulated gene, ubiquitously expressed in normal and malignant cells

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Hormone resistance in prostate cancer is a significant clinical challenge.
• Understanding the genetic mechanisms underlying hormone resistance is crucial for developing new therapies.

Purpose of the Study:

• To identify and characterize novel genes involved in prostate cancer, particularly those related to androgen resistance.
• To investigate the expression patterns of the identified gene in various cancer types and normal tissues.

Main Methods:

• Modified representational difference analysis for gene isolation.
• cDNA sequencing and amino acid sequence analysis.
• Quantitative analysis of gene expression in cell lines and human tissues using mRNA detection.

Main Results:

• A novel gene, prostate androgen regulated (PAR), was identified.
• PAR gene is overexpressed in prostate carcinoma cell lines compared to normal tissue.
• PAR expression is higher in hormone-resistant prostate cancer cells and is not downregulated by androgens.
• PAR mRNA is detected in normal tissues and overexpressed in most malignant counterparts, including breast cancer.

Conclusions:

• The PAR gene is consistently overexpressed in various cancers, suggesting a potential role in tumorigenesis.
• Its differential regulation by androgens in resistant vs. sensitive prostate cancer cells highlights its involvement in hormone resistance.
• The ubiquitous expression in normal tissues and overexpression in malignancies indicate PAR's involvement in fundamental cellular processes and potentially malignant transformation.